Laura Avila1, Noelle Cullinan1, Michael White2, Marian Gaballah3, Anne Marie Cahill3, Deepti Warad4, Vilmarie Rodriguez4, Cristina Tarango5, Anna Hoppmann6, Stephen Nelson7, Tomas Kuhn8, Tina Biss9, Aaron Weiss10, Michael Temple1, João G Amaral1, Nour Amiri1, Ana C Xavier6, Samuele Renzi1, Leonardo R Brandão1. 1. The Hospital for Sick Children, Toronto, Ontario, Canada. 2. Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA. 3. The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. 4. Mayo Clinic, Rochester, Minnesota, USA. 5. Department of Pediatrics, Cincinnati Children's Hospital Medical Centre, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. 6. Children's of Alabama, University of Alabama at Birmingham, Birmingham, Alabama, USA. 7. Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, USA. 8. University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. 9. Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK. 10. Maine Medical Center, Portland, Maine, USA.
Abstract
BACKGROUND: The outcomes of deep vein thrombosis (DVT) in children with May-Thurner Syndrome (MTS) remain unclear. OBJECTIVES: This systematic review and patient-level meta-analysis aims to describe the outcomes of children with MTS presenting with DVT. METHODS: A systematic review of the published literature was performed. Data related to patients <18 years diagnosed with MTS and DVT was extracted. Risk of bias was assessed using the Murad criteria. Outcomes included vessel patency post-treatment, DVT recurrence, and post-thrombotic syndrome (PTS). Predictive and explanatory models were developed for these outcomes. RESULTS: In total, 109 cases were identified (age range 4-17 years; 77 females) in 28 studies; 75% of patients had ≥1 additional risk factor for DVT. PTS was seen in 61% of patients, DVT recurrence in 38%, and complete vessel patency post-treatment in 65%. The models developed to predict and explain PTS performed poorly overall. Recurrent thrombosis (adjusted for age and patency) predicted PTS (odds ratio [OR] 3.36, 95% confidence interval [CI] 1.28-8.82). DVT management strategies (adjusted for age and DVT characteristics) predicted vessel patency (OR 2.10, 95% CI 1.43-3.08). Lack of complete vessel patency (adjusted for age and thrombophilia) predicted recurrent DVT (OR 2.70, 95% CI 1.09-6.67). Sensitivity analyses showed the same direction of effects for all outcomes. CONCLUSIONS: PTS and DVT recurrence occur frequently in pediatric MTS. PTS prediction is complex and it was not possible to identify early predictors to guide clinical practice. Use of imaging-guided therapy and thrombus burden predicted venous patency, and lack of patency predicted DVT recurrence.
BACKGROUND: The outcomes of deep vein thrombosis (DVT) in children with May-Thurner Syndrome (MTS) remain unclear. OBJECTIVES: This systematic review and patient-level meta-analysis aims to describe the outcomes of children with MTS presenting with DVT. METHODS: A systematic review of the published literature was performed. Data related to patients <18 years diagnosed with MTS and DVT was extracted. Risk of bias was assessed using the Murad criteria. Outcomes included vessel patency post-treatment, DVT recurrence, and post-thrombotic syndrome (PTS). Predictive and explanatory models were developed for these outcomes. RESULTS: In total, 109 cases were identified (age range 4-17 years; 77 females) in 28 studies; 75% of patients had ≥1 additional risk factor for DVT. PTS was seen in 61% of patients, DVT recurrence in 38%, and complete vessel patency post-treatment in 65%. The models developed to predict and explain PTS performed poorly overall. Recurrent thrombosis (adjusted for age and patency) predicted PTS (odds ratio [OR] 3.36, 95% confidence interval [CI] 1.28-8.82). DVT management strategies (adjusted for age and DVT characteristics) predicted vessel patency (OR 2.10, 95% CI 1.43-3.08). Lack of complete vessel patency (adjusted for age and thrombophilia) predicted recurrent DVT (OR 2.70, 95% CI 1.09-6.67). Sensitivity analyses showed the same direction of effects for all outcomes. CONCLUSIONS: PTS and DVT recurrence occur frequently in pediatric MTS. PTS prediction is complex and it was not possible to identify early predictors to guide clinical practice. Use of imaging-guided therapy and thrombus burden predicted venous patency, and lack of patency predicted DVT recurrence.
Authors: Suresh Vedantham; Akhilesh K Sista; Seth J Klein; Lina Nayak; Mahmood K Razavi; Sanjeeva P Kalva; Wael E Saad; Sean R Dariushnia; Drew M Caplin; Christine P Chao; Suvranu Ganguli; T Gregory Walker; Boris Nikolic Journal: J Vasc Interv Radiol Date: 2014-07-04 Impact factor: 3.464
Authors: M L Avila; L R Brandão; S Williams; M I Montoya; J Stinson; A Kiss; B M Feldman Journal: J Thromb Haemost Date: 2016-11-23 Impact factor: 5.824
Authors: J P Galanaud; C A Holcroft; M A Rodger; M J Kovacs; M T Betancourt; P S Wells; D R Anderson; I Chagnon; G Le Gal; S Solymoss; M A Crowther; A Perrier; R H White; L M Vickars; T Ramsay; S R Kahn Journal: J Thromb Haemost Date: 2013-03 Impact factor: 5.824
Authors: Elissa R Engel; Anh Thy H Nguyen; Ernest K Amankwah; Manuela Albisetti; Leonardo R Brandão; Neil A Goldenberg; Marisol Betensky Journal: J Thromb Haemost Date: 2020-08-26 Impact factor: 5.824
Authors: Suresh Vedantham; Samuel Z Goldhaber; Jim A Julian; Susan R Kahn; Michael R Jaff; David J Cohen; Elizabeth Magnuson; Mahmood K Razavi; Anthony J Comerota; Heather L Gornik; Timothy P Murphy; Lawrence Lewis; James R Duncan; Patricia Nieters; Mary C Derfler; Marc Filion; Chu-Shu Gu; Stephen Kee; Joseph Schneider; Nael Saad; Morey Blinder; Stephan Moll; David Sacks; Judith Lin; John Rundback; Mark Garcia; Rahul Razdan; Eric VanderWoude; Vasco Marques; Clive Kearon Journal: N Engl J Med Date: 2017-12-07 Impact factor: 176.079
Authors: Lianfu Ji; Fan Yang; Xuan Chen; Jinlong Chen; Xueying Cheng; Jie Yin; Yuming Qin; Shiwei Yang Journal: Front Pediatr Date: 2021-07-15 Impact factor: 3.418